This book presents a selection of the most recent approaches for the production
of novel biotechnological compounds for biomedical applications. In order to
better focus on the challenges at hand, the Editors have striven to adopt an
integrative approach by selecting contributions linking genomics with bacterial
resistance, antibiotics with improved production strategies, optimised
production approaches with chemical development programs, chemical
modifications with new antibody derivatives and biomaterials, the relation
between bioartificial organs and xenotransplantation, apoptosis and process
biotechnology, etc. The different chapters provide an interesting overview of
the current state of the art in the development of truly novel compounds for
biomedical application using recombinant DNA approaches. This book will be of
interest to academic and industrial scientists dealing with biomedical sciences
and for teachers who want to be informed about the latest developments in the
field.
